Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma

BACKGROUND: we have recently shown that Tel-eVax, a genetic vaccine targeting dog telomerase (dTERT) and based on Adenovirus (Ad)/DNA Electro-Gene-Transfer (DNA–EGT) technology can induce strong immune response and increase overall survival (OS) of dogs affected by multicentric Diffuse Large B cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Impellizeri, Joseph A., Gavazza, Alessandra, Greissworth, Eliana, Crispo, Anna, Montella, Maurizio, Ciliberto, Gennaro, Lubas, George, Aurisicchio, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290499/
https://www.ncbi.nlm.nih.gov/pubmed/30537967
http://dx.doi.org/10.1186/s12967-018-1738-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290499/
https://www.ncbi.nlm.nih.gov/pubmed/30537967
http://dx.doi.org/10.1186/s12967-018-1738-6

Ejemplares similares